0001209191-23-015668.txt : 20230303
0001209191-23-015668.hdr.sgml : 20230303
20230303170024
ACCESSION NUMBER: 0001209191-23-015668
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20230301
FILED AS OF DATE: 20230303
DATE AS OF CHANGE: 20230303
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Moore Mary Ann E
CENTRAL INDEX KEY: 0001894731
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-12111
FILM NUMBER: 23705368
MAIL ADDRESS:
STREET 1: 1301 CONCORD TERRACE
CITY: SUNRISE
STATE: FL
ZIP: 33323
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Pediatrix Medical Group, Inc.
CENTRAL INDEX KEY: 0000893949
STANDARD INDUSTRIAL CLASSIFICATION: SERVICES-HOSPITALS [8060]
IRS NUMBER: 263667538
STATE OF INCORPORATION: FL
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 1301 CONCORD TERRACE
CITY: SUNRISE
STATE: FL
ZIP: 33323
BUSINESS PHONE: 9543840175
MAIL ADDRESS:
STREET 1: 1301 CONCORD TERRACE
CITY: SUNRISE
STATE: FL
ZIP: 33323
FORMER COMPANY:
FORMER CONFORMED NAME: MEDNAX, INC.
DATE OF NAME CHANGE: 20090102
FORMER COMPANY:
FORMER CONFORMED NAME: PEDIATRIX MEDICAL GROUP INC
DATE OF NAME CHANGE: 19950801
4
1
doc4.xml
FORM 4 SUBMISSION
X0306
4
2023-03-01
0
0000893949
Pediatrix Medical Group, Inc.
MD
0001894731
Moore Mary Ann E
1301 CONCORD TERRACE
SUNRISE
FL
33323
0
1
0
0
EVP, General Counsel & Sec
Common Stock
16880
I
By Trust
Common Stock
2023-03-01
4
A
0
55664
0.00
A
84700
D
Common Stock
2023-03-01
4
F
0
2345
15.74
D
82355
D
The reporting person and her spouse are trustees of the trust that holds the reported securities. The reporting person disclaims beneficial interest of the reported securities except to the extent of her pecuniary interest therein.
Restricted shares granted pursuant to the Issuer's Amended and Restated 2008 Incentive Compensation Plan (the "Plan"), in connection with an annual equity award. Twenty-five percent (25%) of the restricted shares will vest on March 1, 2024, twenty-five percent (25%) of the restricted shares will vest on March 1, 2025 and fifty percent (50%) of the restricted shares will vest on March 1, 2026, subject to the terms of the Plan.
Excludes 16,340 previously reported shares of restricted common stock granted to the reporting person pursuant to the Plan in connection with an annual equity award that were forfeited because the performance-based criteria were not achieved.
Represents 2,345 restricted shares withheld for payment of taxes upon vesting of shares.
/s/ Mary Ann E. Moore
2023-03-03